PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
Photoplethysmography (PPG) to Predict Ejection Fraction and Other Echographic Data in the General Population
Tulane University
500 participants
Aug 20, 2021
OBSERVATIONAL
Conditions
Summary
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Eligibility
Inclusion Criteria2
- Male or Female aged18 years or older.
- Patients scheduled to undergo an echocardiogram at Tulane Medical Center.
Exclusion Criteria4
- Participants under 18 years of age.
- Participants with cognitive impairments.
- Participants with a physical inability to wear the Biostrap during the echocardiogram.
- Individuals who cannot read, speak, and/or understand English.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Photoplethysmography (PPG) is a non-invasive technique that can detect volumetric changes in the peripheral blood. It only requires skin contact and relies on light absorption. PPG is a good indicator of the cardiovascular dynamics in the human body. PPG has been incorporated into various new smartphones and wearable devices such as, smartwatches and fitness wristbands making it readily available to all consumers. This sensor can record biometrics such as, heart rate, blood pressure, oxygen saturation, etc.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04843371